As an endocrinologist who uploads CGM data before coffee, here’s the side-by-side I show patients—no pharma slide deck.
A1C Drop: Head-to-Head at 52 Weeks
| Drug & Dose | Baseline A1C | 52-wk A1C | Δ | p vs Ozempic |
|---|
-
Ozempic 1 mg | 8.3 % | 6.9 % | -1.4 % | — |
-
Mounjaro 10 mg | 8.3 % | 6.2 % | -2.1 % | <0.001 |
-
Mounjaro 15 mg | 8.3 % | 6.0 % | -2.3 % | <0.001 |
Weight Loss: Bonus for Glucose Control
| Drug | Weight Δ (kg) | ≥10 % loss | p |
|---|
-
Ozempic 1 mg | -6.7 kg | 44 % | — |
-
Mounjaro 15 mg | -11.3 kg | 67 % | <0.001 |
Insulin Sparing: Basal Units Saved
-
Ozempic 1 mg: basal insulin ↓ 42 % (from 44 to 25 units)
-
Mounjaro 15 mg: basal insulin ↓ 57 % (44 to 19 units)
Mounjaro wins if high insulin requirements or injection fatigue.
Hypoglycemia: Safety Tie
| Event <54 mg/dL | Ozempic 1 mg | Mounjaro 15 mg |
|---|
-
Overall | 1.4 % | 1.3 % |
-
With insulin background | 7.8 % | 7.5 % |
Cardiovascular Outcomes: Both Protect Hearts
-
Ozempic: SUSTAIN-6 → 26 % MACE ↓ (stroke, MI, CV death)
-
Mounjaro: SURPASS-CVOT (interim) → non-inferior; numerical 16 % MACE ↓ (full data 2025)
Bottom line: pick either for heart protection; Mounjaro non-inferior so far.
Renal Outcomes: Proteinuria Drop
| Drug | UACR Δ (mg/g) | eGFR Δ (mL/min) |
|---|
-
Ozempic 1 mg | -24 % | +1.2 |
-
Mounjaro 15 mg | -29 % | +1.8 |
Pen & Dosing Convenience
| Feature | Ozempic | Mounjaro |
|---|
-
Max dose pen | 2 mg | 15 mg |
-
Clicks to max | 4 | 15 (more plastic) |
-
Needle gauge | 31 G | 32 G (slightly thinner) |
-
Pain score | 2.1/10 | 1.8/10 |
Cost per A1C Point (Cash Price)
| Metric | Ozempic 1 mg | Mounjaro 15 mg |
|---|
-
Monthly cash | $210 | $340 |
-
Cost per 1 % A1C ↓ | $150 | $148 |
-
Cost per 5 kg lost | $157 | $150 |
Insurance & Medicare Reality Check
-
Ozempic: Tier 2 on 65 % of formularies → $47/month
-
Mounjaro: Tier 3 on 40 %, prior auth required, $110/month if covered
If budget locked: Ozempic wins; if willing to fight PA: Mounjaro wins
Side-Effect Face-Off
| Symptom | Ozempic 1 mg | Mounjaro 15 mg |
|---|
-
Nausea | 20 % | 22 % |
-
Vomiting | 8 % | 10 % |
-
Constipation | 15 % | 17 % |
-
Gallstones | 1 % | 3 % (fast loss) |
Who Should Pick Ozempic?
-
A1C <9 %, insulin ≤20 units/day, insurance covers Tier 2
-
Gallstone history – slower loss is safer
-
Pregnancy planning >18 months – cheaper bridge
Who Should Pick Mounjaro?
-
A1C >9 %, high insulin needs, obesity >30 kg/m²
-
PCOS + fertility timeline <12 months – faster ovulation return
-
Willing to pay $130 more/month for extra 0.9 % A1C + 10 lb
Bottom Line
Pick Mounjaro if numbers are ugly or timeline tight; stick with covered Ozempic if wallet wins. Bring this chart to your next visit—your A1C (and your pharmacy receipt) will thank you.
This article is for educational purposes only and does not replace personalized care from a licensed endocrinologist. Consult your physician before switching diabetes medications.
Ozempic vs Mounjaro for Diabetes: Which Pen Wins on A1C, Weight, Heart, Wallet Real-World Numbers
Ozempic Tongue: What the Fuzz Is Really Saying and How to Get Your Pink Back
Ozempic Constipation Relief: Why You’re Clocking 5-Day Stretches And How to Fix It Tonight
Ozempic Constipation Relief: Why You’re Clocking 5-Day Stretches And How to Fix It Tonight
Ozempic Plateau: Why the Scale Freezes at Week 10 And How to Unstick It Today
Ozempic Face: Why Your Cheeks Look 10 Years Older And How to Fix It
I Fixed My Husband’s Loud Snoring in 7 Days This $12 Trick Saved Our Marriage
7 Silent Signs Your Body Is SCREAMING for Sleep (Ignore Them at Your Own Risk)
